Adecto is a pre-clinical stage, cancer therapeutics company, developing the first targeted therapy against ADAM8-expressing cancers and a companion diagnostic to identify patients who can benefit from it. ADAM8 is a critical driver of the growth and spread of many aggressive tumors, including those of the breast, stomach, colon, lungs, liver and pancreas, and is associated with poor patient survival. Adecto’s current focus is on breast cancer with a plan to expand to other oncology indications in the future. If you are interested in learning more, please visit us at www.adectopharma.com
View Top Employees from Adecto PharmaceuticalsWebsite | http://www.adectopharma.com/ |
Employees | 6 (3 on RocketReach) |
Founded | 2014 |
Address | 75 Kneeland Street 14th floor, Boston, Massachusetts 02111, US |
Technologies |
JavaScript,
HTML,
Twitter
+7 more
(view full list)
|
Industry | Biotechnology Research |
Looking for a particular Adecto Pharmaceuticals employee's phone or email?
Gail SONENSHEIN is the Founder and President of Adecto Pharmaceuticals.
3 people are employed at Adecto Pharmaceuticals.
Adecto Pharmaceuticals is based in Boston, Massachusetts.